Aberrant DNA methylation profile of chronic and transformed classic philadelphia-negative myeloproliferative neoplasms
Aberrant DNA methylation profile of chronic and transformed classic philadelphia-negative myeloproliferative neoplasms
Most DNA methylation studies in classic Philadelphia-negative myeloproliferative neoplasms have been performed on a gene-by-gene basis. Therefore, a more comprehensive methylation profiling is needed to study the implications of this epigenetic marker in myeloproliferative neoplasms. Here, we have analyzed 71 chronic (24 polycythemia vera, 23 essential thrombocythemia and 24 primary myelofibrosis) and 13 transformed myeloproliferative neoplasms using genome-wide DNA methylation arrays. The three types of chronic Philadelphia-negative myeloproliferative neoplasms showed a similar aberrant DNA methylation pattern when compared to control samples. Differentially methylated regions were enriched in a gene network centered on the NF-κB pathway, indicating that they may be involved in the pathogenesis of these diseases. In the case of transformed myeloproliferative neoplasms, we detected an increased number of differentially methylated regions with respect to chronic myeloproliferative neoplasms. Interestingly, these genes were enriched in a list of differentially methylated regions in primary acute myeloid leukemia and in a gene network centered around the IFN pathway. Our results suggest that alterations in the DNA methylation landscape play an important role in the pathogenesis and leukemic transformation of myeloproliferative neoplasms. The therapeutic modulation of epigenetically-deregulated pathways may allow us to design targeted therapies for these patients.
1414-1420
Perez, C.
48c10912-3582-4bc0-9f81-f0cc5856770f
Pascual, M.
33ba3cda-af3c-43c5-bb51-d41b8a1b6e58
Martin-Subero, J. I.
022b042c-dc24-44ac-8eb3-4e51658e9f90
Bellosillo, B.
2895dd73-e11f-473c-8be3-113cd13c511f
Segura, V.
ce482e38-ca49-4fa9-8d80-ae92d060cdae
Delabesse, E.
b62e818f-0a33-428b-9314-b02a05d451c5
Alvarez, S.
d86e9caf-2d00-4313-ad4a-b3455a8401b3
Larrayoz, M. J.
9a26b2f3-2236-402d-86c8-4d5e79b963b2
Rifon, J.
3005c3b0-3866-408a-a6e1-4ca9c0d9611b
Cigudosa, J. C.
2f7c8cc6-59cb-4495-9e83-c0e6ca20e62b
Besses, C.
437843ea-3893-4a4d-9c73-c2820e2d46f0
Calasanz, M. J.
8a1bf9c3-2bf5-4984-ac17-d1970c237316
Cross, N. C. P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Prosper, F.
ae5c673f-f8b0-4195-9531-b1ac5baecc51
Agirre, X.
a6538274-2d63-41c0-9da8-701ebc4b914a
September 2013
Perez, C.
48c10912-3582-4bc0-9f81-f0cc5856770f
Pascual, M.
33ba3cda-af3c-43c5-bb51-d41b8a1b6e58
Martin-Subero, J. I.
022b042c-dc24-44ac-8eb3-4e51658e9f90
Bellosillo, B.
2895dd73-e11f-473c-8be3-113cd13c511f
Segura, V.
ce482e38-ca49-4fa9-8d80-ae92d060cdae
Delabesse, E.
b62e818f-0a33-428b-9314-b02a05d451c5
Alvarez, S.
d86e9caf-2d00-4313-ad4a-b3455a8401b3
Larrayoz, M. J.
9a26b2f3-2236-402d-86c8-4d5e79b963b2
Rifon, J.
3005c3b0-3866-408a-a6e1-4ca9c0d9611b
Cigudosa, J. C.
2f7c8cc6-59cb-4495-9e83-c0e6ca20e62b
Besses, C.
437843ea-3893-4a4d-9c73-c2820e2d46f0
Calasanz, M. J.
8a1bf9c3-2bf5-4984-ac17-d1970c237316
Cross, N. C. P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Prosper, F.
ae5c673f-f8b0-4195-9531-b1ac5baecc51
Agirre, X.
a6538274-2d63-41c0-9da8-701ebc4b914a
Perez, C., Pascual, M., Martin-Subero, J. I., Bellosillo, B., Segura, V., Delabesse, E., Alvarez, S., Larrayoz, M. J., Rifon, J., Cigudosa, J. C., Besses, C., Calasanz, M. J., Cross, N. C. P., Prosper, F. and Agirre, X.
(2013)
Aberrant DNA methylation profile of chronic and transformed classic philadelphia-negative myeloproliferative neoplasms.
Haematologica, 98 (9), .
(doi:10.3324/haematol.2013.084160).
Abstract
Most DNA methylation studies in classic Philadelphia-negative myeloproliferative neoplasms have been performed on a gene-by-gene basis. Therefore, a more comprehensive methylation profiling is needed to study the implications of this epigenetic marker in myeloproliferative neoplasms. Here, we have analyzed 71 chronic (24 polycythemia vera, 23 essential thrombocythemia and 24 primary myelofibrosis) and 13 transformed myeloproliferative neoplasms using genome-wide DNA methylation arrays. The three types of chronic Philadelphia-negative myeloproliferative neoplasms showed a similar aberrant DNA methylation pattern when compared to control samples. Differentially methylated regions were enriched in a gene network centered on the NF-κB pathway, indicating that they may be involved in the pathogenesis of these diseases. In the case of transformed myeloproliferative neoplasms, we detected an increased number of differentially methylated regions with respect to chronic myeloproliferative neoplasms. Interestingly, these genes were enriched in a list of differentially methylated regions in primary acute myeloid leukemia and in a gene network centered around the IFN pathway. Our results suggest that alterations in the DNA methylation landscape play an important role in the pathogenesis and leukemic transformation of myeloproliferative neoplasms. The therapeutic modulation of epigenetically-deregulated pathways may allow us to design targeted therapies for these patients.
This record has no associated files available for download.
More information
Accepted/In Press date: 28 May 2013
Published date: September 2013
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 353646
URI: http://eprints.soton.ac.uk/id/eprint/353646
ISSN: 0390-6078
PURE UUID: 687d44b6-f5d5-4032-b48d-644a12ba2ada
Catalogue record
Date deposited: 12 Jun 2013 15:14
Last modified: 15 Mar 2024 03:11
Export record
Altmetrics
Contributors
Author:
C. Perez
Author:
M. Pascual
Author:
J. I. Martin-Subero
Author:
B. Bellosillo
Author:
V. Segura
Author:
E. Delabesse
Author:
S. Alvarez
Author:
M. J. Larrayoz
Author:
J. Rifon
Author:
J. C. Cigudosa
Author:
C. Besses
Author:
M. J. Calasanz
Author:
F. Prosper
Author:
X. Agirre
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics